Cytokine Profiles of Chronic Urticaria Patients and the Effects of Omalizumab Treatment
Dermatology Practical & Conceptual · 31.10.2023 · e2023272
DOI: 10.5826/dpc.1304a272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 31.10.2023. Verfasst von Ozge Can Bostan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hacettepe University Faculty of Medicine, Department of Chest Diseases, Division of Allergy and Immunology, Ankara, Turkey. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Cytokines are key mediators in immunological and inflammatory conditions, including chronic spontaneous urticaria (CSU).
Objectives
To investigate Th1, Th2, and Th17 cytokine profiles in CSU and to evaluate the possible effect of omalizumab treatment.
Methods
Patients who were followed up for CSU, as well as healthy volunteers, were included in the study. To assess urticaria activity, the 7-day-Urticaria Activity Score (UAS-7), the Urticaria Control Test (UCT), and the Chronic Urticaria Quality of Life Questionnaire (CU-QoL) were filled. Serum levels of IL-6, IL-17, IL-31, eotaxin, RANTES, TNF-α, and TSLP were analyzed by ELISA and compared in CSU and control groups. The patients were analyzed in two groups as the omalizumab group and the non-omalizumab group based on their treatment status.
Results
Total IgE, ESR, CRP, RANTES, and TNF-a were significantly different in the overall comparison of the three groups: CSU-receiving omalizumab, CSU-not receiving omalizumab, and control groups (P
Autor:innen und Institutionen
- Hacettepe University Faculty of Medicine, Department of Chest Diseases, Division of Allergy and Immunology, Ankara, Turkey.
- Hacettepe University Faculty of Science, Department of Biology, Molecular Biology Section, Ankara, Turkey.
- Hacettepe University Faculty of Medicine, Department of Pediatric Allergy and Asthma, Ankara, Turkey.
Zitieren
APA
Can Bostan, O., Damadoglu, E., Sarac, B. E., Kilic, B., Sahiner, U. M., Karaaslan, C., Karakaya, G., & Kalyoncu, A. F. (2023). Cytokine Profiles of Chronic Urticaria Patients and the Effects of Omalizumab Treatment. Dermatology Practical & Conceptual, e2023272. https://doi.org/10.5826/dpc.1304a272
Vancouver
Can Bostan O, Damadoglu E, Sarac BE, Kilic B, Sahiner UM, Karaaslan C, et al. Cytokine Profiles of Chronic Urticaria Patients and the Effects of Omalizumab Treatment. Dermatology Practical & Conceptual. 2023:e2023272. doi:10.5826/dpc.1304a272
BibTeX
@article{CanBostan2023,
author = {Can Bostan, Ozge and Damadoglu, Ebru and Sarac, Basak Ezgi and Kilic, Busra and Sahiner, Umit Murat and Karaaslan, Cagatay and Karakaya, Gul and Kalyoncu, Ali Fuat},
title = {Cytokine Profiles of Chronic Urticaria Patients and the Effects of Omalizumab Treatment},
journal = {Dermatology Practical & Conceptual},
year = {2023},
pages = {e2023272},
doi = {10.5826/dpc.1304a272}
}
EUVIMED